Clinical Trials & Medical Discoveries The most recent news and results from scientific and medical research, including testing, diagnosis, and treatment. Stay up-to-date on the latest medical discoveries and breakthroughs with announcements of new products to be tested, upcoming clinical trials and studies and newly published results. Also included are updates regarding funding decisions, company performance, and legal news.

Latest Clinical Trials & Medical Discoveries

31 Jan, 2018, 08:04 GMT SkylineDx Inks Joint Development Agreement with Mayo Clinic to Develop Diagnostic Tests for Melanoma

SkylineDx today announced a strategic collaboration with Mayo Clinic to develop novel diagnostic tests which will improve clinical decision making...


30 Jan, 2018, 14:05 GMT Unified LifeSphere CTMS™ and LifeSphere EDC™ Help SIRO Clinpharm Improve Clinical Trial Management Productivity and Efficiency

Leading Indian CRO enters partnership with ArisGlobal to enhance its delivery capability in operations and biometrics ArisGlobal, a...


30 Jan, 2018, 08:30 GMT Breakthrough Study Shows that Dexcom G5 Mobile CGM Outperforms Abbott FreeStyle Libre FGM in Reducing Hypoglycaemia

Randomised controlled trial (RCT) assessed impact of two glucose monitoring systems on hypoglycaemia in people with type 1 diabetes DexCom,...


30 Jan, 2018, 07:00 GMT ENDOCUFF VISION® Significantly Improves Adenoma Detection Rate and Colorectal Cancer Detection During Colonoscopy in Bowel Cancer Screening Patients[i]

- ENDOCUFF VISION®increased adenoma detection rate globally from 36.2% to 40.9% (P=0.02)[i] - A total of 56 colorectal cancers...


29 Jan, 2018, 12:33 GMT Study Shows CyberKnife® System Provides Long-Lasting Pain Relief for Trigeminal Neuralgia Patients

CyberKnife Frameless Radiosurgery Offers a Precise and Non-Invasive Technique with Clinical Outcomes Similar to Gamma Knife Frame-Based...


29 Jan, 2018, 07:52 GMT BerGenBio: Encouraging I-O Clinical Data With Selective AXL Inhibitor Bemcentinib (BGB324) Supports its Potential as Cornerstone of Cancer Therapy

- Favourable interim safety data reported across three phase II clinical trials with bemcentinib in combination with KEYTRUDA® (pembrolizumab)...


29 Jan, 2018, 07:00 GMT Norgine Announces Publication of the Prosper Study Design in the Hepatology, Medicine and Policy Journal[i]

- PROSPER is the first Norgine funded European and Australian real world evidence study of patients' experience with hepatic encephalopathy...


26 Jan, 2018, 07:45 GMT Flow Neuroscience Raises 1.1M USD in Seed Round Lead by Khosla Ventures to Develop a Device to Treat Depression

Flow Neuroscience, a Sweden-based medtech company is developing a new treatment for depression combining brain stimulation with behavioral...


25 Jan, 2018, 20:04 GMT Stryker's DAWN Trial results contribute to updated acute ischemic stroke guidelines from the American Heart Association and American Stroke Association

Yesterday the American Heart Association and American Stroke Association updated the ischemic stroke guidelines. The new recommendation expanded...


25 Jan, 2018, 09:00 GMT Rexgenero Treats First Patient in its Phase III Programme with Lead Product REX-001, a Novel Cell Therapy for the Treatment of Critical Limb Ischemia (CLI)

Rexgenero Ltd, a clinical-stage regenerative medicine company developing advanced cell-based therapies with a focus on Critical Limb Ischemia...


25 Jan, 2018, 07:42 GMT Alligator Bioscience Contracts Theradex Oncology as Clinical CRO for the Upcoming ATOR-1015 Phase I Study

Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy,...


24 Jan, 2018, 23:30 GMT GW Pharmaceuticals and its U.S. Subsidiary Greenwich Biosciences Announce Publication of Landmark Epidiolex® (Cannabidiol) Study in The Lancet

- First well-controlled clinical study of cannabidiol in Lennox-Gastaut syndrome, a rare, severe, form of childhood-onset epilepsy that is...


24 Jan, 2018, 00:01 GMT Synthetic Virus to Tackle Antimicrobial Resistance

The National Physical Laboratory (NPL) and UCL researchers have created an artificial virus which kills bacteria on first contact NPL, the...


23 Jan, 2018, 13:01 GMT Superbugs: First Independent Comparison of Pharma Companies' Efforts to Address Drug-resistant Infections

The first independent analysis of pharmaceutical industry efforts to tackle drug resistance, published today, finds that as well as...


23 Jan, 2018, 12:00 GMT Silver Offers Hope of Solving the Antibiotics Crisis - Bacterial Resistance to Nanoparticles can be Averted

Scientists from the Palacký University (UP) in Olomouc have discovered a unique mechanism that enables bacteria to defend themselves against...


22 Jan, 2018, 14:00 GMT BERG Announces FDA Orphan-Drug Designation of BPM31510 for the Treatment of Pancreatic Cancer

BERG, a Boston-based biopharmaceutical company that merges biology with technology to map the nature of diseases, today announced the U.S. Food and...


22 Jan, 2018, 10:19 GMT European Patent Office Cancels Oral Opposition Proceedings Concerning Cantargia's Patent for Hematological Cancers

In the ongoing opposition proceedings at the European Patent Office ("EPO") concerning Cantargia AB's ("Cantargia") patent for antibody treatment...


19 Jan, 2018, 14:06 GMT Historic Deal Signed Between Panacea Biotec and Serum Institute of India

Panacea Biotec Ltd. (PBL), India's leading biopharmaceutical company and among the largest manufacturer of vaccines, has signed two long-term...


18 Jan, 2018, 19:48 GMT Single Blood Test Screens For Eight Cancer Types

Provides unique new framework for early detection of the most common cancers Johns Hopkins Kimmel Cancer Center researchers developed a...


18 Jan, 2018, 13:00 GMT Daiichi Sankyo Presents Updated Data for DS-8201 in Patients with HER2-Expressing Gastric Cancer at ASCO 2018 Gastrointestinal Cancers Symposium

- Updated analysis from ongoing phase 1 study of DS-8201 demonstrated a confirmed overall response rate of 45.5 percent and a disease control rate...


18 Jan, 2018, 00:00 GMT GC Pharma Confirms Phase 2/3 Clinical Trial of New Protein Therapy for Hepatitis B

First Recombinant Treatment for Most Common Liver Transplantation Risk GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280), a...


17 Jan, 2018, 13:51 GMT Technology Advancements to Conquer the Precision Medicine Market

Chimeric Antigen Receptor (CAR) T Cell therapy prove effective in treating hematological cancers, with close to 90% clinical response rate...


17 Jan, 2018, 10:00 GMT OBI Pharma Announces FDA Clearance Of IND Application For A Phase 1 Study Of A Monoclonal Antibody Cancer Immunotherapy (OBI-888).

First Clinical Trial to Test the Safety and Preliminary Activity of Passive Immunotherapy based on a Monoclonal Antibody targeting Globo H, a...


17 Jan, 2018, 06:00 GMT Pharming Announces FDA Acceptance for Review of Supplemental Biologics License Application for RUCONEST® for Prophylaxis of Hereditary Angioedema Attacks

Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announced today that the U.S. Food and Drug Administration (FDA) has...


16 Jan, 2018, 14:00 GMT MyDx's Biopharmaceutical Division Commences Clinical Trials On Its Unique MyDx360 Pain Management Formula

Partnering with the Leading Israeli Research and Development Organizations and Hospitals Devoted to the Scientific Study of Cannabis MyDx,...